Phillip A. Sharp - Aug 15, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role: Director
Signature: By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Phillip A. Sharp
Stock symbol: ALNY
Transactions as of: Aug 15, 2022
Transactions value $: -$6,623,670
Form type: 4
Date filed: 8/17/2022, 04:07 PM
Previous filing: Jun 2, 2022
Next filing: May 19, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALNY	Common Stock	Options Exercise	$903K	+30K		$30.09^*	30K	Aug 15, 2022	Direct	F1
transaction	ALNY	Common Stock	Options Exercise	$234K	+3.67K	+12.23%	$63.86	33.7K	Aug 15, 2022	Direct	F1
transaction	ALNY	Common Stock	Sale	-$22.2K	-98	-0.29%	$226.16	33.6K	Aug 15, 2022	Direct	F1
transaction	ALNY	Common Stock	Sale	-$278K	-1.22K	-3.63%	$228.33	32.4K	Aug 15, 2022	Direct	F1, F2
transaction	ALNY	Common Stock	Sale	-$2.67M	-11.6K	-35.85%	$229.93	20.8K	Aug 15, 2022	Direct	F1, F3
transaction	ALNY	Common Stock	Sale	-$3.73M	-16.2K	-77.99%	$230.71	4.57K	Aug 15, 2022	Direct	F1, F4
transaction	ALNY	Common Stock	Sale	-$893K	-3.85K	-84.35%	$231.65	715	Aug 15, 2022	Direct	F1, F5
transaction	ALNY	Common Stock	Sale	-$166K	-715	-100%	$232.81	0	Aug 15, 2022	Direct	F1, F6
holding	ALNY	Common Stock						267K	Aug 15, 2022	by Trust	F7

Showing 1 to 9 of 9 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALNY	Stock Option (right to buy)	Options Exercise	$0	-3.67K	-100%	$0.00^*	0	Aug 15, 2022	Common Stock	3.67K	$63.86	Direct	F1, F8
transaction	ALNY	Stock Option (right to buy)	Options Exercise	$0	-30K	-100%	$0.00^*	0	Aug 15, 2022	Common Stock	30K	$30.09	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2022.
F2	Sale prices ranged from $228.00 to $228.80.
F3	Sale prices ranged from $229.29 to $230.29.
F4	Sale prices ranged from $230.30 to $231.30.
F5	Sale prices ranged from $231.31 to $232.26.
F6	Sale prices ranged from $232.53 to $233.16.
F7	Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.
F8	The stock option was fully vested as of 12/31/14.